Hola,
Are you new here?

VISION

financed

Strategies to strengthen scientific excellence and innoVation capacIty for early...

Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSIs of gastrOintestinal caNcers Slovakia belongs to countries with the highest incidence of colorectal and pancreatic cancer in Europe. Therefore, the main goal of the VISION proposal is to strengthen the scientific excellence and innovative capacity of Biomedic... see more

30/06/2023

BIOMEDICAL RESEARC...

787K€

Project Budget: 787K€

Project leader

BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

PARTICIPATION DEPralty Sin fecha límite de participación.

Ver 6 Participantes

Financing granted El organismo H2020 notifico la concesión del proyecto The day 2023-06-30

WIDESPREAD-03-2018: Twinning Specific Challenge:The specific challenge is to enhance networking activities between the research i...

I+D

Cerrada does 6 years

0% 100% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

6 Participantes

BIOMEDICAL RESEARCH CENTER O...

270.00K€ | Leader

FUNDACION PARA LA INVESTIGAC...

131.25K€ | participant

SERMAS

132.50K€ | participant

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project duration: 47 months Date Start: 2019-07-09
End date: 2023-06-30

Project leader

BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Project Budget 787K€

participation deadline Sin fecha límite de participación.

Project description Slovakia belongs to countries with the highest incidence of colorectal and pancreatic cancer in Europe. Therefore, the main goal of the VISION proposal is to strengthen the scientific excellence and innovative capacity of Biomedicinske centrum Slovenskej akademie vied (BMC SAV), in early detection of gastrointestinal cancer (GI). Creation of a strategic partnership between the coordinator from widening county, BMC SAV and four internationally-recognized institutions, Fraunhofer-Gesellschaft zur Foerderung der Angewandten Forschung e.V. (FhG), Ramón y Cajal University Hospital Health Research Institute represented by Servicio Madrileno de Salud, (SERMAS), Ethniko Kai Kapodistriako Panepistimio Athinon (NKUA), and Norsk Institutt for Luftforskning Stiftelse (NILU) will enhance the credibility and recognition of BMC SAV in European research area. Transfer of knowledge and research ideas, sharing of know-how, expertise and best practices, together with the implementation of cutting edge-technologies, will contribute to the enhancement of high-quality translational cancer research at BMC SAV, particularly GI cancer. Collaboration and networking between VISION partners will accelerate the personal and professional development of early stage researchers and medical doctors, impact the rate of success in internationally competitive research funding and high-quality peer-reviewed publications. Involvement of VISION partners in mentoring and co-supervision of PhD will increase the quality of education at universities, mainly medical and natural science faculties. Moreover, regional and outreach activities supported by VISION will lead to enhanced public awareness of cancer and the importance of prevention.

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers